Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Sanofi Genzyme hit with patent lawsuit over new eczema drug
Bizjournals.com
Thu, 04/20/17 - 09:48 am
Tags:
Sanofi Genzyme, patents, eczema, Dupixent, Immunex, Amgen
3 Big Drugmakers Most Likely to Buy Incyte
Motley Fool
Wed, 04/12/17 - 11:57 am
Tags:
Incyte, M&A, Gilead Sciences, Amgen, Bristol-Myers Squibb
Amgen Files Marketing Applications to Expand Xgeva's Use to US and EU MM Patients
Yahoo/GuruFocus
Mon, 04/10/17 - 10:02 am
Tags:
Amgen, Xgeva, Multiple Myeloma, Europe
3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Sun, 04/9/17 - 12:36 pm
Tags:
Regeneron, Praluent, Amgen, biosimilars, Amjevita, Humira, ABP-215, Avastin, ABP-980, Herceptin, Celgene, ozanimod
Earnings Preview: Biotechnology Looks Healthy
Barron's
Sat, 04/8/17 - 12:52 pm
Tags:
earnings, biotech, Amgen, Celgene, Vertex Pharmaceutials, Biogen, Akorn
[video]What's Next for Amgen's Repatha?
Motley Fool
Tue, 04/4/17 - 07:24 pm
Tags:
Amgen, Repatha
Amgen will move 100 workers to San Francisco, Cambridge as part of restructuring
Bizjournals.com
Tue, 04/4/17 - 12:15 am
Tags:
Amgen, restructuring, layoffs, R&D
FDA Grants Priority Review For Amgen's BLINCYTO® (blinatumomab) Supplemental Biologics License Application
Yahoo
Wed, 03/29/17 - 05:01 pm
Tags:
Amgen, FDA, priority review, Blincyto, acute lymphoblastic leukemia
3 Drugmakers With Boatloads of Cash to Spend
Motley Fool
Wed, 03/29/17 - 04:54 pm
Tags:
Pfizer, Gilead Sciences, Amgen, JNJ, M&A
Amgen triggers yet another revamp, moving researchers to two big hubs
Endpoints
Mon, 03/27/17 - 10:29 am
Tags:
Amgen, restructuring, R&D
$5B in Humira sales at stake with Amgen EU approval
BioPharma Dive
Sat, 03/25/17 - 12:18 pm
Tags:
Humira, Amgen, Europe, rheumatoid arthritis, Amgevita, biosimiliars
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor
Xtalks
Thu, 03/23/17 - 10:13 pm
Tags:
Amgen, patients, PCSK9 inhibitors, Repatha
Biotechs Back in the Doghouse After Failed Rally
Investopedia
Thu, 03/23/17 - 09:57 pm
Tags:
biotech, Gilead Sciences, Amgen
How This Company Is Taking on Amgen
Motley Fool
Thu, 03/23/17 - 09:54 pm
Tags:
Amgen, Medicines Company, Repatha, inclisiran
Sanofi, Regeneron Sue Amgen to Avoid Dupixent Patent Claims
Investopedia
Wed, 03/22/17 - 09:58 am
Tags:
Sanofi, Regeneron, Dupixent, Amgen, patents, eczema
Why Amgen's Success Was a Big Disappointment
Motley Fool
Mon, 03/20/17 - 11:03 pm
Tags:
Amgen, Repatha, heart attacks, stroke
Amgen Blew It…For Medicines Co., Esperion Too
Barron's
Sun, 03/19/17 - 11:25 am
Tags:
Amgen, Medicines Company, Esperion Therapeutics, Repatha, inclisiran
Express Scripts says Amgen data opens door to patients
Yahoo/Reuters
Sun, 03/19/17 - 10:39 am
Tags:
Express Scripts, Amgen, Repatha, patients
CVS Health says Amgen data may increase eligible patients by millions
Yahoo/Reuters
Sun, 03/19/17 - 10:37 am
Tags:
CVS Health, Amgen, Repatha, patients
Amgen Drug Prevents Heart Attacks, Not Deaths, Disappointing Experts
Forbes
Fri, 03/17/17 - 11:33 am
Tags:
Amgen, Repatha, heart attacks, stroke, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.